9,10-dimethyl-1,2-benzanthracene has been researched along with metformin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Alhaider, AA; Ansari, MA; Denison, MS; El-Kadi, AO; Ghebeh, H; Korashy, HM; Maayah, ZH; Soshilov, AA | 1 |
Kurhaluk, N; Tkachenko, H | 1 |
Patel, PJ; Shah, JS | 1 |
3 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and metformin
Article | Year |
---|---|
Metformin inhibits 7,12-dimethylbenz[a]anthracene-induced breast carcinogenesis and adduct formation in human breast cells by inhibiting the cytochrome P4501A1/aryl hydrocarbon receptor signaling pathway.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Breast Neoplasms; Carcinogenesis; Carcinogens; Cell Line, Tumor; Cytochrome P-450 CYP1A1; DNA Adducts; Female; Guanine; Humans; Metformin; Mice; NAD(P)H Dehydrogenase (Quinone); Receptors, Aryl Hydrocarbon; RNA, Messenger; Signal Transduction | 2015 |
Effects of melatonin and metformin in preventing lysosome-induced autophagy and oxidative stress in rat models of carcinogenesis and the impact of high-fat diet.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Autophagy; Carcinogenesis; Diet, High-Fat; Female; Humans; Lysosomes; Mammary Neoplasms, Experimental; Melatonin; Metformin; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2022 |
Metformin pretreatment potentiates the antiproliferative action of doxorubicin against breast cancer.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Doxorubicin; Female; Metformin; Neoplasms; Rats; Rats, Wistar | 2023 |